Sutro Biopharma Inc buy Truist Financial Co.
Start price
03.04.24
/
50%
€4.78
Target price
03.04.25
€16.65
Performance (%)
-26.78%
Price
09.05.24
€3.92
Summary
This prediction is currently active. The prediction for Sutro Biopharma Inc disappoints with a performance of -26.78%. This prediction currently runs until 03.04.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sutro Biopharma Inc | 15.789% | 15.789% |
iShares Core DAX® | 4.015% | 2.971% |
iShares Nasdaq 100 | 2.755% | 0.503% |
iShares Nikkei 225® | -0.826% | -5.057% |
iShares S&P 500 | 2.330% | 0.720% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Sutro Biopharma Inc diskutieren
Sutro Biopharma, Inc. (NASDAQ: STRO) had its price target lowered by analysts at Truist Financial Co. from $25.00 to $18.00. They now have a "buy" rating on the stock.
Ratings data for STRO provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Sutro Biopharma Inc
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€4.14
06.09.23
06.09.23
€23.30
06.09.24
06.09.24
-5.80%
09.05.24
09.05.24